Literature DB >> 327607

Properties of washed human platelets.

R L Kinlough-Rathbone, J F Mustard, M A Packham, D W Perry, H J Reimers, J P Cazenave.   

Abstract

We have shown previously that washed human platelets resuspended in Tyrode solution containing albumin and apyrase maintain their disc shape and their ability to aggregate upon the addition of low concentration of ADP, providing fibrinogen is added to the suspending medium. We have now examined their responses to other aggregating and release-inducing agents. Collagen, arachidonate, thrombin, immune serum globulin, the ionophore A23, 187 and phytohaemagglutinin from Phaseolus vulgaris caused aggregation and release of granule contents. The response to adrenaline was variable. Serotonin caused the platelets to change shape but no aggregation or release occurred. Addition of a small amount of plasma was necessary for ristocetin-induced aggregation. Polylysine caused immediate platelet-to-platelet adherence with little or no release of granule contents. Responses to collagen or thrombin were greater in a modified medium containing magnesium but no calcium; in this medium, aggregation caused by ADP or polylysine was followed by the release of granule contents whereas these agents caused aggregation without release in a medium with both calcium and magnesium. When protein was omitted from the suspending medium, platelet aggregation in response to ADP was variable. In this medium, collagen and thrombin caused more extensive release than in the albumin-containing medium. Aggregation by polylysine was accompanied by release and extensive lysis in the protein-free medium. Thus, the composition of the final resuspending medium has a major effect on the responses of washed human platelets to aggregating agents.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 327607

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  15 in total

1.  Demonstration and characterization of specific binding sites for factor VIII/von Willebrand factor on human platelets.

Authors:  K J Kao; S V Pizzo; P A McKee
Journal:  J Clin Invest       Date:  1979-04       Impact factor: 14.808

2.  A new variant of Glanzmann's thrombasthenia (Strasbourg I). Platelets with functionally defective glycoprotein IIb-IIIa complexes and a glycoprotein IIIa 214Arg----214Trp mutation.

Authors:  F Lanza; A Stierlé; D Fournier; M Morales; G André; A T Nurden; J P Cazenave
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

Review 3.  Platelet responses in health and disease.

Authors:  M I Barnhart
Journal:  Mol Cell Biochem       Date:  1978-12-22       Impact factor: 3.396

4.  Role of immunoglobulin G in platelet aggregation by viridans group streptococci.

Authors:  P M Sullam; G A Jarvis; F H Valone
Journal:  Infect Immun       Date:  1988-11       Impact factor: 3.441

5.  Platelet-activating factor (PAF-acether): thromboxane-independent synergism with adrenaline on human platelets and recent insights into its mode of action.

Authors:  F Fouque; D Joseph; B B Vargaftig
Journal:  Agents Actions       Date:  1982-12

6.  Potentiation by adrenaline of human platelet activation and the inhibition by the alpha-adrenergic antagonist nicergoline of platelet adhesion, secretion and aggregation.

Authors:  F Lanza; J P Cazenave; A Beretz; A Sutter-Bay; J G Kretz; R Kieny
Journal:  Agents Actions       Date:  1986-08

7.  Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid.

Authors:  J P Brammer; M H Maguire
Journal:  Br J Pharmacol       Date:  1984-05       Impact factor: 8.739

8.  Triggering by Paf-acether and adrenaline of cyclo-oxygenase-independent platelet aggregation.

Authors:  F Fouque; B B Vargaftig
Journal:  Br J Pharmacol       Date:  1984-11       Impact factor: 8.739

9.  Inhibition of the activation of Hageman factor (factor XII) by peripheral blood cells.

Authors:  O D Ratnoff; M M Emanuelson; N P Ziats
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808

10.  Inhibition of aggregation and secretion of human platelets by quercetin and other flavonoids: structure-activity relationships.

Authors:  A Beretz; J P Cazenave; R Anton
Journal:  Agents Actions       Date:  1982-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.